Quick Takeaways
- BAKER BROS. ADVISORS LP filed SCHEDULE 13G for Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2024.
BAKER BROS. ADVISORS LP - 31 Dec 2024 SCHEDULE 13G Report for Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL)
- Filing Manager
- BAKER BROS. ADVISORS LP
- Reporting Manager
- Baker Bros. Advisors LP
- Symbol
- CADL
- Shares outstanding
- 43,852,691 shares
- Disclosed Ownership
- 2,981,983 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 16:14:18 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAKER BROS. ADVISORS LP disclosed 6.8% ownership in Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 6.8% | 2,981,983 | 2,981,983 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/President, Baker Bros. Advisors (GP) LLC, its general partner | |
| Baker Bros. Advisors (GP) LLC | 6.8% | 2,981,983 | 2,981,983 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/President | |
| Julian C. Baker | 6.8% | 2,981,983 | 2,981,983 | 0 | /s/ Julian C. Baker | Julian C. Baker | |
| Felix J. Baker | 6.8% | 2,981,983 | 2,981,983 | 0 | /s/ Felix J. Baker | Felix J. Baker |